MEDEKA, s.r.o.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• COPD3 trials

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed2 trials
• Not yet recruiting1 trial

Lead sponsor

• Chiesi Farmaceutici S.p.A.2 trials
• UCB Biopharma SRL1 trial

Running trials

• Recruiting

  A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis

  NCT07725939· Phase 2· UCB Biopharma SRL· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting

Closed trials

• Completed

  The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy

  NCT04636814· Phase 3· Chiesi Farmaceutici S.p.A.· Source

• Completed

  The efficacy and the safety of two doses of CHF6001 for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

  NCT04636801· Phase 3· Chiesi Farmaceutici S.p.A.· Source